Investor RelationsFinancial Analysis

Financial Analysis

Historical Data

Financial Performance

Q1 2023Q2 2023Q3 2023Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025฿0M฿200M฿400M฿600M฿800M
Latest Quarter
฿390.73M
+0.9% vs prior quarter
Period High
฿702.06M
All time high
Period Average
฿528.20M
Average over 12 quarters

Earnings Simulator

Adjust segment growth rates to model projected quarterly outcomes

Projections are hypothetical and for illustrative purposes only

Projected Total Revenue

฿1731M

+233.0% vs Q3'24

Projected EBITDA Margin

27.4%

+3.5pp vs Q3'24

Projected EBITDA

฿474M

Q3 2025E

Fastest Growing Segment

Ampul

+4% QoQ

Segment Growth Rates

QoQ assumptions
-20%
+40%
Base: ฿400M▲ 17% over 4QQ3'25E: ฿467.9M
-20%
+40%
Base: ฿250M▲ 17% over 4QQ3'25E: ฿292.5M
-20%
+40%
Base: ฿500M▲ 17% over 4QQ3'25E: ฿584.9M
-20%
+40%
Base: ฿330M▲ 17% over 4QQ3'25E: ฿386.1M

Revenue Mix — Q3'25E

Cleansing27.0%
Body16.9%
Collagen33.8%
Ampul22.3%

Quarterly Revenue by Segment

Historical + projected (฿M)

Actual
Projected
Cleansing Serum
Body Cream
Collagen
Ampul
Q3'23Q4'23Q1'24Q2'24Q3'24Q4'24EQ1'25EQ2'25EQ3'25E฿0M฿450M฿900M฿1350M฿1800MToday

Blended EBITDA Margin

Historical + projected (%)

Q3'25E: 27.4%
Q3'23Q4'23Q1'24Q2'24Q3'24Q4'24EQ1'25EQ2'25EQ3'25E23.1%24.2%25.3%26.4%27.5%

* Projected margins are model estimates only. EBITDA margin sensitivity assumes a 0.18pp margin expansion/contraction per 1% of quarterly growth rate adjustment.

Investor Relations

MADAME BIOSCIENCES

Financial & Valuation Report

Prepared: 30 September 2026

For internal and investor use only. For reference only. Not investment advice.

Investment Parameters

Valuation

N/Ax
P/E Ratio
1.12x
P/BV Ratio
N/Ax
EV/EBITDA
0.00%
Dividend Yield

Profitability

N/A%
ROE
N/A%
ROA
-8.91%
Net Profit Margin
N/A%
Gross Profit Margin

Efficiency

0.24x
D/E Ratio
N/Ax
Current Ratio

Growth

N/A%
Revenue Growth YoY
N/A%
EBIT Growth YoY

Financial Summary

Metric20212022202320242025
Revenue50556579100
COGS3035.7542.954.5155
Gross Profits2019.2522.124.4945
%GP40%35%34%31%45%
SG&A1012111214
EBIT107.2511.112.4931
%EBIT20%13%17%16%31%
Interests21123
Taxes43214
Net Profits43.258.19.4924
%NP8%6%12%12%24%
Growth—81%249%117%253%

Financial Charts

Revenue & Profit

202120222023202420250255075100
  • Revenue
  • Gross Profits
  • Net Profits

Profit Margins (%)

202120222023202420250%15%30%45%60%
  • %GP
  • %NP
  • %EBIT

P/E vs P/BV Peer Comparison — Valuation Positioning Map

0481216P/E Ratio (x)00.651.31.952.6P/BV Ratio (x)Avg P/EAvg P/BVKAMART88THDDD
CompanyTickerP/E (x)P/BV (x)
KarmartsKAMART13.3x2.48x
88 (Thailand)88TH8.8x1.57x
Do Day DreamDDD0.3x0.34x
Sector Average7.5x1.46x

Data sourced from public sources via AI. For reference only. Not investment advice.

Cookie Policy

We use cookies to enhance your browsing experience, analyze site usage, and deliver relevant content, in accordance with the Personal Data Protection Act (PDPA).

Read more: Cookie Policy · Privacy Policy